Therapeutic Management of Nonhospitalized Adults With COVID-19 – NIH
Last Updated: July 21, 2023 Nonhospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines (nih.gov)
Higher COVID-19 Testing Rates for Nursing Home Staff Are Associated with Fewer Resident Infections and Deaths
https://www.jwatch.org/na55913/2023/03/23/higher-covid-19-testing-rates-nursing-home-staff-are March 23, 2023 Higher COVID-19 Testing Rates for Nursing Home Staff Are Associated with Fewer Resident Infections and Deaths Thomas L. Schwenk, MD, reviewing McGarry BE et al. N…
Study Comparing Surgical and N95 Masks Sparks Concern
https://www.medscape.com/viewarticle/984992#vp_1 Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers : A Randomized Trial – PubMed (nih.gov) “The confidence intervals around this, that is, what the possible…
No title here
blahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblah
COVID-19 natural immunity versus vaccination | Nebraska Medicine Omaha, NE
https://www.nebraskamed.com/COVID/covid-19-studies-natural-immunity-versus-vaccination
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network
Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms…
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir – Merck.com
https://www.merck.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir/
Statement on Ivermectin | COVID-19 Treatment Guidelines
It works in a petri dish but the concentration of drug that would have to get into the lungs to be effective might not be possible in a person without…